Last reviewed · How we verify
Prevention of Motion Sickness
Approved treatments
- Antivert · Generic (originally Pfizer/UCB)
- Antivert · Citron Pharma Llc
- Dimenhydrinate · Alra
- scopolamin · University Hospital, Angers
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Prevention of Motion Sickness patent landscape — cliff calendar, originator estates, attackable patents
- Prevention of Motion Sickness treatment landscape brief
- Prevention of Motion Sickness treatment updates RSS
Frequently asked questions about Prevention of Motion Sickness
What drugs treat Prevention of Motion Sickness?
Tracked treatments include Antivert, Dimenhydrinate, scopolamin.
What is the treatment for Prevention of Motion Sickness?
Standard treatment for Prevention of Motion Sickness includes Antivert, Dimenhydrinate, scopolamin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Prevention of Motion Sickness patent cliff · Prevention of Motion Sickness CI report
- Treatment: Antivert · Generic (originally Pfizer/UCB)
- Treatment: Antivert · Citron Pharma Llc
- Treatment: Dimenhydrinate · Alra
- Treatment: scopolamin · University Hospital, Angers
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing